Luyan Pharma Co (SZSE:002788) 5-Year EBITDA Growth Rate : 11.30% (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Luyan Pharma Co 5-Year EBITDA Growth Rate?

Luyan Pharma Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.41.

During the past 12 months, Luyan Pharma Co's average EBITDA Per Share Growth Rate was 1.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 8.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 11.30% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 11.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Luyan Pharma Co was 32.20% per year. The lowest was -5.00% per year. And the median was 12.15% per year.

Competitive Comparison of Luyan Pharma Co's 5-Year EBITDA Growth Rate

For the Pharmaceutical Retailers subindustry, Luyan Pharma Co's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Luyan Pharma Co's 5-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Luyan Pharma Co's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Luyan Pharma Co's 5-Year EBITDA Growth Rate falls into.

Luyan Pharma Co 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Luyan Pharma Co (SZSE:002788) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Luyan Pharma Co 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Luyan Pharma Co's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Luyan Pharma Co (SZSE:002788) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Luyan Pharma Co Ltd (SZSE:002788) » Definitions » 5-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

1004 Ridge Road, Huli District, Fujian Province, Xiamen City, CHN, 361 010

Website

http://www.luyan.com.cn

Luyan Pharma Co Ltd, formerly Luyan (Fujian) Pharma Co Ltd engages in the production, operation, distribution, and retail of human health products in China. It provides medical and health products.

Executives

Zhu Ming Guo	Executives
Yang Cong Jin	Directors, executives
Lei Ming	Directors, executives
Li Wei Yang	Executives
Cai Mei Zhen	Supervisors
Li Cui Ping	Supervisors
Wu Jin Xiang	Directors, executives
Zhang Jun Ying	Executives
Wu Huo Lu	Director

Luyan Pharma Co (SZSE:002788) Headlines

No Headlines